Boston Scientific (BSX) Net Equity Issued and Repurchased (2009 - 2020)

Boston Scientific has disclosed Net Equity Issued and Repurchased across 12 years of filings, most recently posting $933.0 million for Q2 2020.

• In Q2 2020, Net Equity Issued and Repurchased rose 1860.38% year-over-year to $933.0 million; the TTM figure through Sep 2021 stood at $933.0 million (down 4.31% YoY), while the FY2020 annual figure was $975.0 million, changed N/A from the prior year.
• Net Equity Issued and Repurchased came in at $933.0 million for Q2 2020 at Boston Scientific, up from $42.0 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $933.0 million in Q2 2020 to a low of -$94.0 million in Q4 2018.
• Average Net Equity Issued and Repurchased over 5 years is $73.2 million, with a median of $34.0 million recorded in 2016.
• Year-over-year, Net Equity Issued and Repurchased sank 1666.67% in 2018 and soared 1860.38% in 2020.
• Over 5 years, Net Equity Issued and Repurchased stood at $3.0 million in 2016, then soared by 100.0% to $6.0 million in 2017, then slumped by 1666.67% to -$94.0 million in 2018, then soared by 43.62% to -$53.0 million in 2019, then soared by 1860.38% to $933.0 million in 2020.
• Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $933.0 million in Q2 2020, $42.0 million in Q1 2020, and -$53.0 million in Q2 2019.